Cargando…

An open-label randomized controlled trial of leflunomide in patients with acute SARS-CoV-2 omicron variant infection

OBJECTIVE: To evaluate the efficacy and safety of leflunomide for the treatment of acute, symptomatic COVID-19. METHODS: A single-center, open-label, randomized controlled trial was performed during an outbreak of SARS-CoV-2 Omicron variant in December 2022. Symptomatic patients within 5 days of COV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Zhou, Wan, Zhihui, Wang, Yixuan, Zha, Shiqian, Zhang, Jingyi, Chen, Hao, Hu, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392126/ https://www.ncbi.nlm.nih.gov/pubmed/37534317 http://dx.doi.org/10.3389/fmed.2023.1218102

Ejemplares similares

Performance of leflunomide as a steroid-sparing agent in giant cell arteritis: A single-center, open-label study
por: Kramarič, Jelka, et al.
Publicado: (2022)

Chinese Herbal Formula Huayu-Qiangshen-Tongbi Decoction Compared With Leflunomide in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis: An Open-Label, Randomized, Controlled, Pilot Study
por: Wu, Jiaqi, et al.
Publicado: (2020)

Comparison of clinical characteristics between SARS-CoV-2 Omicron variant and Delta variant infections in China
por: Li, Qinggang, et al.
Publicado: (2022)

Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?
por: Rodriguez-Sevilla, Juan Jose, et al.
Publicado: (2022)

Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
por: Zhang, Jianguo, et al.
Publicado: (2022)

Genomic profile of SARS-CoV-2 Omicron variant and its correlation with disease severity in Rajasthan
por: Sharma, Ravi P., et al.
Publicado: (2022)

Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern
por: Mazzaferri, Fulvia, et al.
Publicado: (2022)

The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial
por: Zhong, Weijie, et al.
Publicado: (2022)

A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial
por: Hu, Ke, et al.
Publicado: (2020)

SARS-CoV-2 Omicron Variant in Patients With Chronic Lymphocytic Leukemia: Case Series
por: Khamees, Ibrahim, et al.
Publicado: (2022)

Leflunomide/rituximab: SARS-CoV-2 infection: case report
Publicado: (2021)

SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study
por: Ali, Elrazi A, et al.
Publicado: (2022)

Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial
por: Xu, Xiangru, et al.
Publicado: (2023)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)

Bacterial coinfections in hospitalized children with COVID-19 during the SARS-CoV-2 Omicron BA.2 variant pandemic in Taiwan
por: Lai, Huan-Cheng, et al.
Publicado: (2023)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Evaluation of COVID-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of SARS-CoV-2 omicron variant in Shanghai
por: Yang, Dawei, et al.
Publicado: (2023)

Analysis of risk factors and short-term prognostic factors of arrhythmia in patients infected with mild/moderate SARS-CoV-2 Omicron variant
por: Yan, Lijie, et al.
Publicado: (2023)

Infection with the SARS-CoV-2 Omicron variant in children with congenital heart disease: A case series study during Shanghai epidemic
por: Yang, Yinyu, et al.
Publicado: (2022)

Leflunomide/methotrexate: Visceral leishmaniasis and SARS-CoV-2 infection: case report
Publicado: (2022)

SARS-CoV-2 reinfections during the Delta and Omicron waves
por: Morris, C. Paul, et al.
Publicado: (2022)

SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge
por: Woldemeskel, Bezawit A., et al.
Publicado: (2022)

The Discovery, Validation, and Function of Hypoxia-Related Gene Biomarkers for Obstructive Sleep Apnea
por: Wu, Xiaofeng, et al.
Publicado: (2022)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
por: Li, Fu, et al.
Publicado: (2022)

Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron
por: van Dorp, Christiaan, et al.
Publicado: (2022)

Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron
por: van Dorp, Christiaan, et al.
Publicado: (2022)

Cobblestone Throat in a Younger Patient Infected with the Omicron Variant of the SARS-CoV-2 Virus
por: Inui, Genki, et al.
Publicado: (2023)

Implemented occupational health surveillance limits the spread of SARS-CoV-2 Omicron at the workplace
por: Gesto, João Silveira Moledo, et al.
Publicado: (2022)

Mathematical appraisal of SARS-CoV-2 Omicron epidemic outbreak in unprecedented Shanghai lockdown
por: Jiang, Minghao, et al.
Publicado: (2022)

Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
por: Wei, Changshuo, et al.
Publicado: (2021)

PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
por: Su, Jingyi, et al.
Publicado: (2022)

Tracking SARS-CoV-2 Variants Using a Rapid Typification Strategy: A Key Tool for Early Detection and Spread Investigation of Omicron in Argentina
por: Castro, Gonzalo M., et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant: recent progress and future perspectives
por: Fan, Yao, et al.
Publicado: (2022)

Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds
por: FUKUSHIMA, Kenjiro, et al.
Publicado: (2015)

Comparison of the efficacy of cyclosporine and leflunomide in treating inflammatory colorectal polyps in miniature dachshunds
por: TANI, Akiyoshi, et al.
Publicado: (2020)

A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants
por: Wang, Chang Yi, et al.
Publicado: (2022)

Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: From alpha to Omicron
por: Yu, Choo Yee, et al.
Publicado: (2022)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fe5rj2g1on5rl3m0vpl82ua3al